tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Novocure downgraded to Equal Weight from Overweight at Wells Fargo

Wells Fargo analyst Larry Biegelsen downgraded Novocure (NVCR) to Equal Weight from Overweight with a price target of $14.50, down from $40.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1